Read + Share
Amedeo Smart
Independent Medical Education
Nie H, Liao L, Zielinski RJ, Gomez JA, et al. Selective Alanine Transporter Utilization is a Therapeutic Vulnerability in ARID1A-Mutant Ovarian Cancer. Cancer Res 2025 Jul 14. doi: 10.1158/0008-5472.CAN-25-0654.PMID: 40658600
Email
LinkedIn
Privacy Policy